iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Firstsource Solutions Limited has informed the Exchange regarding Allotment of 164813 Shares.

image

Godrej Consumer Products Limited has informed the Exchange about Schedule of meet

image

Glenmark Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

image

Siyaram Silk Mills Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Feb-2022.

image

SREI Infrastructure Finance Limited has informed the Exchange about Loss of Share Certificates

image

Jyothy Labs Limited has informed the Exchange regarding Change in Director(s) of the company.

image

Birla Corporation Limited has informed the Exchange regarding a press release dated January 21, 2022, titled Integrated cement plant of RCCPL, wholly owned subsidiary of Birla Corporation Limited, inaugurated at Mukutban, taking Group capacity to 20 million tons.

image

HUL

Whatsapp
Facebook
Twitter
LinkedIn

Net Sales up 10.33%

image

Strides Pharma Science today announced its partnership with Medicines Patent Pool (MPP) to commercialize molnupiravir in the international markets. Strides and its subsidiary, Universal Corporation (Kenya), have entered into a voluntary non?]exclusive sub?]license partnership with MPP covering 105 countries as part of MSD (NYSE: MRK, a trading name of Merck & Co., Inc, Kenilworth, NJ, USA) and MPP?fs partnership to enable a global reach for […]

image

SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool to manufacture molnupiravir, an investigational oral antiviral Covid- 19 medicine, to increase broad access of treatment in 105 low- and middle-income countries. Powered by Capital Market – Live News

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.